What is a Family History Assessment Tool?
A family history assessment tool (FHAT) is a structured screening instrument—ranging from brief questionnaires to comprehensive three-generation pedigrees—designed to systematically collect information about cancer and other diseases in a patient's relatives to identify hereditary risk patterns and guide clinical decision-making.
Core Purpose and Clinical Utility
Family history assessment tools serve as critical risk stratification instruments that enable clinicians to:
- Identify individuals with hereditary cancer susceptibility syndromes who require genetic counseling and testing 1
- Determine empiric cancer risk in patients without identified genetic mutations but with concerning family patterns 1
- Guide screening and prevention strategies based on familial risk profiles 2
- Reduce morbidity and mortality by enabling early detection and risk-reducing interventions 1
The fundamental goal is to allow providers to determine whether a patient may have a hereditary cancer susceptibility syndrome, would benefit from genetic counseling, or requires more intensive surveillance than someone with sporadic disease 1.
Spectrum of Tools: From Brief to Comprehensive
The Gold Standard: Three-Generation Pedigree
The comprehensive three-generation pedigree represents the gold standard used in medical genetics and genetic counseling settings 1. However, this approach is labor-intensive and impractical for routine clinical practice in busy oncology or primary care settings 1.
Practical Alternatives: Brief Screening Tools
For routine clinical use, brief self-completed questionnaires have been developed and validated 3, 4. These tools balance comprehensiveness with feasibility:
- 6-item family history questionnaires demonstrate excellent diagnostic accuracy (sensitivity 81-98%, specificity 81-94%) for identifying increased risk of diabetes, ischemic heart disease, breast cancer, and colorectal cancer 4
- Self-administered formats allow patients to complete assessments before or between visits, reducing clinician time burden 3, 4
- Web-based platforms like Health Heritage© can guide users through family history collection, generate pedigrees automatically, and provide risk assessments for up to 89 conditions 5
Minimum Adequate Family History: ASCO Framework
The American Society of Clinical Oncology defines the minimum adequate family history for cancer patients as including first- and second-degree relatives with specific key elements 1:
Required Information for Each Affected Relative:
- Type of primary cancer(s)
- Age at diagnosis of each primary cancer
- Lineage (maternal and/or paternal)
Relative Categories:
- First-degree relatives: Parents, children, full siblings
- Second-degree relatives: Grandparents, aunts/uncles, nieces/nephews, grandchildren, half siblings
Additional Critical Elements:
- Known hereditary cancer predisposition syndromes in the family
- Prior genetic testing results
- Ethnicity information relevant to genetic risk (e.g., Ashkenazi Jewish ancestry increases BRCA1/2 mutation prevalence, requiring lower testing thresholds) 1
Both maternal and paternal lineages must be assessed separately, even for sex-specific cancers like breast and ovarian cancer, because autosomal-dominant transmission can occur through either parent 1.
Clinical Performance and Validation
Accuracy Considerations
Research reveals important limitations in current tools:
- Analytical and clinical validity is poorly reported across most available tools 3
- Sensitivity is generally acceptable, but specificity is poor in approximately half of reviewed tools 3
- Family history accuracy decreases with more distant relatives, making focus on first- and second-degree relatives most reliable 1
Effectiveness in Risk Identification
Despite limitations, validated tools successfully identify 6.2-84.6% of individuals at high or moderate increased risk 3. Specific tools like FHAT have demonstrated effectiveness in:
- Minimizing unnecessary referrals while capturing mutation-positive individuals 6
- Identifying women with FHAT scores ≥10 who have an odds ratio of 15.23 for breast cancer compared to those with scores of 0 7
- Outperforming usual care by identifying 60% of elevated risk conditions versus 24% with standard approaches 5
Implementation Barriers and Solutions
Current Challenges
Electronic health record systems lack adequate functionality to capture and utilize family history data effectively 1:
- Most EHRs cannot consume HL7 pedigree standard messages despite it being the recognized standard 1
- Interoperability between patient tools (like My Family Health Portrait) and physician systems remains problematic 1
- Time constraints and unclear reimbursement policies create systemic barriers 1
Recommended Solutions
EHR vendors should integrate family history platforms with built-in risk models and pedigree drawing capabilities 1. The ideal system would:
- Include core family history information requirements
- Provide built-in clinical decision support
- Interface with external risk model software using HL7 standards 1
Practical Application Algorithm
For Oncology Providers:
- At cancer diagnosis: Collect minimum adequate family history (first- and second-degree relatives, cancer types, ages at diagnosis, lineage) 1, 2
- Update periodically throughout care 2
- Use risk models (e.g., Claus model for breast cancer) when family history suggests elevated but not hereditary-level risk 1
- Refer for genetic counseling when patterns suggest hereditary syndromes per NCCN or specialty society criteria 1
For Primary Care Providers:
- Implement brief self-completed screening questionnaires for systematic assessment 4
- Focus on common chronic diseases: diabetes, ischemic heart disease, breast cancer, colorectal cancer 4
- Use positive screens to trigger detailed pedigree and risk assessment 4
- Apply evidence-based screening modifications based on family history findings 1
Critical Pitfalls to Avoid
- Don't limit assessment to maternal lineage for breast/ovarian cancer—paternal transmission is equally important 1
- Don't rely solely on patient recall for distant relatives—accuracy decreases significantly beyond first- and second-degree relatives 1
- Don't overlook ethnicity-specific risk factors—failure to ask about Ashkenazi Jewish ancestry can miss opportunities for appropriate BRCA testing 1
- Don't assume negative family history eliminates risk—small family size or early deaths may mask hereditary patterns 1